AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Cannabis Use and Atherosclerotic Cardiovascular Disease Among US Adults

By Dalal N, Divya A

Background: Cannabis use has increased in the United States, but its association with atherosclerotic cardiovascular disease (ASCVD) remains uncertain, particularly because of tobacco co-use. We examined the association between cannabis use frequency and prevalent ASCVD in a nationally representative sample, with prespecified sensitivity analyses among never-smokers and young adults without major cardiovascular risk factors. Methods: We analyzed pooled 2020-2024 Behavioral Risk Factor Surveillance System data from states that included the marijuana use module. Adults were categorized by past-month cannabis use as none, low, moderate, or heavy use. ASCVD was defined as self-reported myocardial infarction, coronary heart disease/angina, or stroke. Survey-weighted logistic regression adjusted for demographics, tobacco smoking, alcohol use, obesity, diabetes, hypertension, chronic kidney disease, physical inactivity, education, and income. Prespecified analyses evaluated sex interaction, never-smokers, young low-risk adults, temporal trends, and state recreational legalization. Results: Among 577,057 adults, any cannabis use increased from 10.5% in 2020 to 16.0% in 2024, a 52% relative increase. In the primary adjusted analysis, cannabis use was directionally associated with higher ASCVD odds across frequency categories, although estimates did not reach statistical significance. A significant cannabis-by-sex interaction was observed, with stronger associations among women. Among women, moderate cannabis use was significantly associated with ASCVD. In never-smokers, low-frequency cannabis use was independently associated with ASCVD. Among adults aged 18-44 years without diabetes, hypertension, or obesity, heavy cannabis use was significantly associated with ASCVD. Associations were stronger in states with recreational legalization. Conclusion: Cannabis use was associated with higher ASCVD odds in key subgroups, including never-smokers, women, and young adults without traditional risk factors. These findings support incorporating cannabis exposure into cardiovascular risk assessment and prevention counseling.

doi.org/10.1161/circ.154.suppl_1.8457Populations

AgingResearch.News